When UK private equity firm Permira in May last year bought a majority stake in Israeli fraud protection firm BioCatch at a $1.3 billion valuation — as the country was still at war with the Hamas terror group — investors cashed in handsome returns. The deal also benefited Israeli youth, soldiers and victims of the October 7, 2023 onslaught, thanks to the sale of options worth $1.3 million, originally donated in 2015 by BioCatch to the the nonprofit organization Tmura.

Read more here.